Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Ajanta Pharma has informed that: a. The Forty-Seventh Annual General Meeting (‘AGM’) of the Members of the Company will be held on Thursday, 16th July 2026 at 11:00 am (IST) through Video Conferencing (‘VC’) / Other Audio-Visual Means (‘OAVM’), in compliance with the applicable provisions of the Companies Act, 2013 and the relevant circulars issued by the Ministry of Corporate Affairs and the Securities and Exchange Board of India. b. For the purpose of dispatch of the Annual Report for FY 2025-26 and the Notice convening the 47th AGM, the beneficiary position of shareholders as received from the Depositories as on Friday, 12th June 2026 will be considered. c. The cut-off date for determining the eligibility of Members to vote on the resolutions proposed to be passed at the 47th AGM shall be Thursday, 9th July 2026. The Notice convening the AGM and the Annual Report for FY 2025-26 will be dispatched to the Members in due course and will also be made available on the website of the Company.
The above information is a part of company’s filings submitted to BSE.
